Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT03702582
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 100 participants
- Registry
-
NCT03702582
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03702582. Randomized; no masking; primary purpose prevention. Start 2019-04-30 (actual); primary completion 2023-10-01 (actual). Results posted on 2026-05-19.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation
- Acronym
- NEW-AF
- Condition
- Atrial Fibrillation
- Condition
- Stroke
- Condition
- Bleeding
- Intervention (Drug)
- Rivaroxaban
- Intervention (Drug)
- Warfarin
- Lead sponsor
- Massachusetts General Hospital
Record details
- Record id
cardio:ct-nct03702582- Content hash
fd94183819efb824c15ce1f446e12e904137e6ea8ec7c2b05b7fb6342ed5a2b5